Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation

BACKGROUND: Most patients with multiple myeloma (MM) are considered to be incurable, and relapse owing to minimal residual disease (MRD) is the main cause of death among these patients. Therefore, new technologies to assess deeper response are required. PATIENTS AND METHODS: We retrospectively analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamatsu, H., Takezako, N., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Murata, R., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., Yoshida, T., Faham, M., Nakao, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834061/
https://www.ncbi.nlm.nih.gov/pubmed/28945825
http://dx.doi.org/10.1093/annonc/mdx340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834061/
https://www.ncbi.nlm.nih.gov/pubmed/28945825
http://dx.doi.org/10.1093/annonc/mdx340

Ejemplares similares